Entyvio

Takeda tries again with subcutaneous Entyvio
Takeda tries again with subcutaneous Entyvio
Pharmaphorum
Takeda
Entyvio
ulcerative colitis
Flag link:
Not IDEAL: Protagonist sinks as high dose of oral Entyvio rival fails in ulcerative colitis
Not IDEAL: Protagonist sinks as high dose of oral Entyvio rival fails in ulcerative colitis
Fierce Biotech
Protagonist Therapeutics
clinical trials
ulcerative colitis
Entyvio
Flag link:
The top 15 blockbuster patent expirations coming this decade
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Flag link:
Early Morphic data hint at a threat to Entyvio
Early Morphic data hint at a threat to Entyvio
EP Vantage
Morphic Therpeuitc
Entyvio
MORF--57
Takeda
Flag link:
Roche’s test of novel gut target nears
Roche’s test of novel gut target nears
EP Vantage
Roche
ulcerative colitis
etrolizumab
Takeda
Entyvio
Flag link:
Takeda’s Entyvio Ad Captures Struggle to Make Plans
Takeda’s Entyvio Ad Captures Struggle to Make Plans
Xtalks
Takeda
DTC ads
inflammatory bowel disease
Entyvio
Flag link:
Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
BioSpace
Takeda
Entyvio
AbbVie
Humira
ulcerative colitis
Flag link:
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
CP Wire
Takeda
vedolizumab
ulcerative colitis
Entyvio
Flag link:
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Takeda
Entyvio
ulcerative colitis
Chron's Disease
Flag link:
Takeda pursuing needle-free delivery for its top-selling biologic
Takeda pursuing needle-free delivery for its top-selling biologic
BioPharma Dive
Takeda
needle free delivery
Portal Instruments
devices
Entyvio
Flag link:
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Stat
Crohn’s disease
HIV
vedolizumab
Entyvio
Takeda
Flag link:
Takeda Acquires U.S. Biologics Manufacturing Facility
Takeda Acquires U.S. Biologics Manufacturing Facility
Yahoo
Takeda
drug manufacturing
Entyvio
Flag link:
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Takeda
FDA
Entyvio
vedolizumab
ulcerative colitis
Crohn's Disease
Flag link:
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Takeda
vedolizumab
Entyvio
ulcerative colitis
Crohn's Disease
Flag link: